Not registered yet? Click here
In Vitro Antibacterial Efficacy of Cetylpyridinium Chloride-Containing Mouthwashes
Lyndsay Schaeffer, Ph.D.
The in vitro effect of three 0.075% CPC mouthwashes on the viability of two common oral bacteria.
Upon completion of reading these articles, the clinician will be able to:
- Understand the in vitro methodology used to determine the antimicrobial efficacy of mouthwash formulations.
- Understand the measurements used to determine the reduction of oral bacteria by mouthwashes.
Disclosure: Dr. Schaeffer, Dr. Szewczyk, Mr. Nesta, Dr. Vandeven, Dr. Du-Thumm, Dr. Williams, and Dr. Arvanitidou are employees of the Colgate-Palmolive Company.
Release date: Monday, November 21, 2011
Expiration date: Friday, November 21, 2014
"In Vitro Antibacterial Efficacy of Cetylpyridinium Chloride-Containing Mouthwashes" is co-sponsored by Dental Tribune America, LLC. Dental Tribune America LLC is a recognized ADA CERP provider.
The author will answer your questions
There are no comments, questions or opinions posted yet. Be the first to comment on this article, it's easy! Just use the box below to write your message and the click "Submit the new thread".
Lyndsay Schaeffer , Ph.D.
Lyndsay Schaeffer works as a Technical Associate at Colgate-Palmolive Company in Piscataway, NJ, USA. She has eight years of experience in oral care research, including work on bacterial interactions with toothpaste and mouthwash ingredients and studies of bacterial toxin regulation.
Lyndsay received her doctorate in molecular genetics, biochemistry and microbiology from the University of Cincinnati College of Medicine, Cincinnati, OH. She received post-doctoral training at the University of Louisville Dental School.